LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all people with CLL have to have therapy. Inspite of all latest innovations, the iwCLL continue to suggests watchful observation for patients with asymptomatic disease.86 This recommendation is based on a minimum of two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (